Top

Why Donald Trump’s Putative FDA Pick Could Scare Pharma

December 9, 2016

Via: Forbes
Category:

Yesterday, Bloomberg reported that Donald Trump is considering nominating venture capitalist and libertarian Jim O’Neill to head the Food and Drug Administration, and some in the pharmaceutical industry experienced an increasingly strong sense of nausea.

O’Neill, works at Mithril Capital, the firm founded by Paypal and Facebook backer Peter Thiel. That alone could normally serve to generate concerns about conflicts of interest with medical firms he helped to found.

Read More on Forbes